We are live on ! Find out more
ARCT icon

Arcturus Therapeutics
ARCT

179 hedge funds and large institutions have $919M invested in Arcturus Therapeutics in 2024 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 54 increasing their positions, 63 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

83% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 18

12% more capital invested

Capital invested by funds: $820M → $919M (+$98.7M)

8% more funds holding

Funds holding: 165 → 179 (+14)

3.8% more ownership

Funds ownership: 97.34% → 101.13% (+3.8%)

1% less call options, than puts

Call options by funds: $11M | Put options by funds: $11.1M

14% less repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 63

Holders
179
Holders Change
+14
Holders Change %
+8.48%
% of All Funds
2.58%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
33
Increased
54
Reduced
63
Closed
18
Calls
$11M
Puts
$11.1M
Net Calls
-$79K
Net Calls Change
+$63K

Top Buyers

1
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$15.9M
2
BlackRock
BlackRock
New York
+$12.2M
3
State Street
State Street
Massachusetts
+$11.7M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$11.3M
5
Wellington Management Group
Wellington Management Group
Massachusetts
+$7.95M

Top Sellers

1
AIM
ARK Investment Management
Florida
-$12.7M
2
Morgan Stanley
Morgan Stanley
New York
-$10.5M
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$8.59M
4
WP
Woodline Partners
California
-$5.51M
5
GIM
Granahan Investment Management
Massachusetts
-$4.05M
Name Holding Trade Value Shares
Change 		Change in
Stake
Federated Hermes
1
Federated Hermes
Pennsylvania
$159M -$572K -16,140 -0.3%
BlackRock
2
BlackRock
New York
$92.6M +$12.2M +344,706 +14%
State Street
3
State Street
Massachusetts
$66.2M +$11.7M +330,270 +20%
AIM
4
ARK Investment Management
Florida
$57.1M -$12.7M -358,038 -17%
Vanguard Group
5
Vanguard Group
Pennsylvania
$46.9M -$2.5M -70,486 -5%
Sumitomo Mitsui Trust Group
6
Sumitomo Mitsui Trust Group
Japan
$43.1M -$1.56M -44,133 -3%
NAMA
7
Nikko Asset Management Americas
New York
$43M -$1.56M -44,133 -3%
Dimensional Fund Advisors
8
Dimensional Fund Advisors
Texas
$37.3M +$528K +14,890 +1%
WP
9
Woodline Partners
California
$30.9M -$5.51M -155,450 -15%
Morgan Stanley
10
Morgan Stanley
New York
$29.3M -$10.5M -295,547 -25%
Fidelity Investments
11
Fidelity Investments
Massachusetts
$21M -$8.59M -242,500 -28%
Geode Capital Management
12
Geode Capital Management
Massachusetts
$18.6M +$425K +11,998 +2%
Adage Capital Partners
13
Adage Capital Partners
Massachusetts
$15.2M +$15.9M +450,000 New
Goldman Sachs
14
Goldman Sachs
New York
$12.3M -$1.82M -51,271 -12%
JAM
15
Jupiter Asset Management
United Kingdom
$12.2M – – –
SSA
16
Schonfeld Strategic Advisors
New York
$11.7M -$1.95M -54,987 -14%
GIM
17
Granahan Investment Management
Massachusetts
$11.4M -$4.05M -114,219 -25%
Point72 Asset Management
18
Point72 Asset Management
Connecticut
$11.3M +$11.3M +317,800 +1,808%
JP Morgan Chase
19
JP Morgan Chase
New York
$10.7M -$187K -5,268 -2%
Wellington Management Group
20
Wellington Management Group
Massachusetts
$9.63M +$7.95M +224,274 +369%
PCM
21
Portolan Capital Management
Massachusetts
$8.26M +$3.5M +98,805 +68%
Northern Trust
22
Northern Trust
Illinois
$8M -$356K -10,057 -4%
American Century Companies
23
American Century Companies
Missouri
$7.83M +$7.65M +215,799 +1,353%
GLA
24
Great Lakes Advisors
Illinois
$7.1M +$116K +3,264 +2%
Bank of America
25
Bank of America
North Carolina
$6.71M +$5.62M +158,494 +396%
1
2 3 4 5

ARCT Hedge Fund Activity: Q1 2024 in Review

179 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Arcturus Therapeutics (ARCT) for Q1 2024, worth a combined $919M — up 12% from $820M a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new ARCT positions and 18 closed out — a net gain of 15 holders — while 54 added to existing stakes and 63 trimmed.

The largest buyer was Adage Capital Partners, opening a new position worth an estimated $15.9M. The largest seller was ARK Investment Management, cutting an estimated $12.7M.

  • 179 institutional investors held Arcturus Therapeutics (ARCT) as of Q1 2024, up from 165 in Q4 2023.
  • Funds reported $919M of Arcturus Therapeutics stock for Q1 2024, up 12% quarter-over-quarter.
  • 33 funds opened new Arcturus Therapeutics positions in Q1 2024 and 18 closed out, a net change of +15 holders.
  • The largest Arcturus Therapeutics buyer in Q1 2024 was Adage Capital Partners, an estimated $15.9M added.
  • The largest Arcturus Therapeutics seller in Q1 2024 was ARK Investment Management, an estimated $12.7M sold.

Based on aggregated 13F filings for Q1 2024.